NEWS!
🎇 Read our
2022 Year in Review
Investing in AI-first companies.
🏡 Home
👋 Team
🤓 Blog
✉️ Newsletter
📖 State of AI
🛍️ Merch
Epoch II ('22-)
Samaya AI
. Enterprise knowledge discovery (USA);
Profluent
. Protein language models (USA);
Enveda
. Medicines from nature (USA);
Epoch I ('19-'22)
Adept
. Useful General Intelligence (USA);
Allcyte (acq. Exscientia)
. Precision oncology (AUT);
Anagenex
. DNA-encoded libraries (USA);
Athenian
. Data-enabled engineering (FR);
CellVoyant
. See the future in cells (UK);
ClipDrop (acq. Stability AI)
. AI-first photos (FR);
Coram AI
. Video intelligence (UK/USA);
Exscientia (NASDAQ: EXAI)
. Patient-first AI (UK);
Gandeeva
. Structural biology for drug design (CA);
Gourmey
. Cell-based meat (FR);
Graphcore
. Semiconductors for AI (UK);
Hedera
. Liquid biopsies for cancer care (FI/CH);
Intenseye
. Workplace safety (TR);
LabGenius
. Protein therapeutics (UK);
Mission Barns
. Lab-grown fat (USA);
Modern Intelligence
. One AI for defense (USA);
Recursion (NASDAQ: RXRX)
. Drug discovery (USA);
Stability AI
. Truly open AI (UK/USA);
Valence Discovery (acq. Recursion)
. Drug discovery (CA);
V7
. Computer vision data platform (UK);
ZOE
. Eat what's good for you (UK);
pre-Air Street
Andela
. Remote engineering teams (USA);
Crusoe
. Climate-friendly computation (USA);
Jukedeck (acq. ByteDance)
. AI-first music (UK);
Mapillary (acq. Facebook)
. Better maps (SE);
Numerai
. The world's open hedge fund (USA);
Optimal
. Autonomous indoor farms (UK);
PolyAI
. AI voice assistants (UK);
Ravelin
. Fraud prevention (UK);
Recursion (NASDAQ: RXRX)
. Drug discovery (USA);
Flow Engineering
. Collaborative engineering (UK);
Thought Machine
. Core banking (UK);
Tractable
. AI for insurance (UK);
Starship
. Self-driving delivery robots (Estonia);
Stripe
. Online payments (USA);
Synthesia
. AI videos from text. (UK);
Wayve
. Self-driving: AV2.0 (UK);